Tools

LEADER 02540nai 2200553 i 4500

001 on1119389918;

003 OCoLC;

005 20191023090207.0;

006 m o d f ;

007 cr mn|||||||||;

008 190912c20189999dcu x w obb f0 2eng c;

010 a| 2019256653;

035 a| (Sirsi) o1119389918;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0807-A-07 (online);

086 0 a| LC 14.23:R 44703/;

100 1 a| Johnson, Judith A.q| (Judith Ann),d| 1957-e| author.=| ^A1366984;

245 10 a| Generic drugs and GDUFA reauthorization :b| in brief /c| Judith A. Johnson.;

246 1 a| Generic drugs and Generic Drug User Fee Amendments reauthorization;

250 a| [Library of Congress public edition].;

264 1 a| [Washington, D.C.] :b| Congressional Research Service,c| 2018-;

300 a| 1 online resource.;

310 a| Updated irregularly;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| Report / Congressional Research Service ;v| R44703;

500 a| The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2017.;

500 a| CRDP Program record.;

504 a| Report includes bibliographical references.;

588 a| Description based on contents viewed on Sept. 6, 2019; title from CRS report home page.;

610 10 a| United States.t| Drug Price Competition and Patent Term Restoration Act of 1984.=| ^A571334;

610 10 a| United States.t| Generic Drug User Fee Amendments of 2012.=| ^A1383184;

650 0 a| Patent medicinesx| Law and legislationz| United States.=| ^A854852;

650 0 a| User chargesx| Law and legislationz| United States.=| ^A1023613;

650 0 a| Generic drugsx| Law and legislationz| United States.=| ^A434409;

710 2 a| Library of Congress.b| Congressional Research Service,e| issuing body.=| ^A1690;

773 08 i| Contained in (work):t| CRS reports (Library of Congress. Congressional Research Service)w| (DLC) 2018231131w| (OCoLC)1052784408;

830 0 a| CRS report ;v| R44703.=| ^A1365572;

856 40 u| https://purl.fdlp.gov/GPO/gpo125252;

922 a| CRSREP;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5185718;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5185718-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 10/14/2019x| EDOCUMENTz| JERESOURCE;

Generic drugs and GDUFA reauthorization in brief / Judith A. Johnson.

Author/creator	Johnson, Judith A., 1957- author.
Other author	Library of Congress. Congressional Research Service, issuing body.
Format	Electronic
Edition	[Library of Congress public edition].
Publication	[Washington, D.C.] : Congressional Research Service, 2018-
Description	1 online resource.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo125252
Subjects	United States. Drug Price Competition and Patent Term Restoration Act of 1984. United States. Generic Drug User Fee Amendments of 2012. Drugs--Prices. --Law and legislation. --United States. Patent medicines--Law and legislation. --United States. User charges--Law and legislation. --United States. Generic drugs--Law and legislation. --United States.

Variant title	Generic drugs and Generic Drug User Fee Amendments reauthorization
Frequency	Updated irregularly
Series	Report / Congressional Research Service ; R44703 CRS report ; R44703. ^A1365572
General note	The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2017.
General note	CRDP Program record.
Bibliography note	Report includes bibliographical references.
Source of description	Description based on contents viewed on Sept. 6, 2019; title from CRS report home page.
In	Contained in (work): CRS reports (Library of Congress. Congressional Research Service)
LCCN	2019256653
GPO item number	0807-A-07 (online)
Govt. docs number	LC 14.23:R 44703/

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Generic drugs and GDUFA reauthorization in brief / Judith A. Johnson.

Click here for more information about this title

Availability